About This Insulin Infusion Rate Calculator
This Insulin Infusion Rate Calculator converts a continuous IV regular insulin order into a pump rate. Adult ICUs run insulin for two jobs — hyperglycemic crises (DKA and HHS), ordered weight-based in units/kg/hr, and routine glucose control, where nurse-driven protocols titrate a flat units/hr rate. The tool accepts either unit and shows both, with the mL/hr rate and the 24-hour total.
The preset follows the ASHP Standardize 4 Safety standard concentration for glycemic-control infusions: 1 unit/mL. ASHP lists a second standard, 16 units/mL, solely for high-dose insulin therapy in calcium-channel-blocker or beta-blocker overdose — a separate order set this tool does not convert. Insulin is a high-alert medication: the converter does not recommend a rate, and the guideline content restated here does not replace your institution’s approved order set. The potassium and hypoglycemia gates are hard stops, not background reading.
The Formulas Explained
Concentration (units/mL) = Total Insulin (units) ÷ Final Volume (mL)
Rate (mL/hr) = Dose (units/hr) ÷ Concentration (units/mL)
To convert units/kg/hr to mL/hr, this insulin infusion rate calculator takes the hourly dose first: Dose (units/hr) = Dose (units/kg/hr) × Weight (kg). At 1 unit/mL the final division changes nothing — 0.1 units/kg/hr in an 80 kg patient is 8 units/hr and the pump runs at 8.00 mL/hr. In a 0.5 units/mL bag the same order runs at 16.00 mL/hr, which is why the concentration sits directly above the rate table.
The bolus row uses 0.1 units/kg — optional in the 2024 consensus, considered when a delay in obtaining venous access is anticipated, and it may be given IV or IM. A single dose drawn from a U-100 vial, not an hourly rate, and not used in HHS.
Clinical Interpretation & Limitations
In DKA the infusion is a fixed-rate protocol, not a titration to a glucose target. Resolution is biochemical — blood ketones below 0.6 mmol/L with venous pH ≥7.3 or bicarbonate ≥18 mmol/L — not a glucose number, which is why the rate is reduced rather than stopped once dextrose goes up. The expected 50–75 mg/dL per hour fall is a 2009 consensus figure the 2024 report does not restate. HHS differs: fluids carry more of the treatment, insulin starts at 0.05 units/kg/hr when there is no significant ketonemia, and the glucose decline is held to no more than 90–120 mg/dL per hour. The full pathway is in our DKA & HHS treatment guideline below.
For general ICU glucose control the evidence question is the target, not the drug. NICE-SUGAR randomized 6,104 critically ill adults and found higher 90-day mortality with an 81–108 mg/dL target (27.5% vs 24.9%) than with a conventional target of 180 mg/dL or less; severe hypoglycemia was far more common in the intensive arm (6.8% vs 0.5%), though the trial did not establish that it caused the excess deaths. Nurse-driven column protocols implement the titration; this insulin infusion rate calculator converts the ordered rate and reproduces no titration table.
Starting and maintenance dose
Start at 0.1 units/kg/hr for DKA — 7 units/hr at 70 kg — with no bolus required. For non-DKA control there is no single guideline starting rate; nurse-driven protocols derive the initial rate from the current glucose and an insulin-sensitivity factor, then titrate to the 140–180 mg/dL band. The rows in the table are conversion steps, not a normal range: requirements vary several-fold with steroids, vasopressors, nutrition, obesity and sepsis, and rates above the top row are routine in insulin-resistant patients.
Potassium, dextrose and the checkpoints that matter
- K+ below 3.5 mmol/L: hold insulin and replace potassium (about 10 mmol/hr) until K+ is at least 3.5.
- K+ 3.5–5.0 mmol/L: start insulin and add 20–30 mmol of potassium per liter of fluid, targeting 4–5 mmol/L.
- K+ above 5.0 mmol/L: start insulin without added potassium; recheck in 2 hours.
- Glucose below 250 mg/dL in DKA: add 5–10% dextrose and reduce to 0.05 units/kg/hr rather than stopping.
- Euglycemic DKA: about 10% of DKA presents with glucose below 200 mg/dL, and SGLT2 inhibitors now account for most of those cases. Dextrose is started alongside the saline from the outset rather than added later, and the diagnosis rests on ketones and acidosis, never on the glucose number.
- Glucose below 70 mg/dL: treat immediately with IV dextrose and recheck. In non-DKA control, hold the infusion until glucose recovers; in DKA, raise the dextrose and reduce the rate rather than stopping, because the ketoacidosis is still being treated.
Organ dysfunction and special situations
- Renal impairment: insulin is partly cleared by the kidney, so requirements fall and hypoglycemia risk rises in AKI, CKD and dialysis.
- Concentration and stability: the Humulin R label supports IV use at 0.1–1 unit/mL in 0.9% sodium chloride, and a prepared bag is stable for 48 hours refrigerated and then up to 48 more at room temperature. Outside that range is a preparation question, not a rate question.
- Rising requirements: corticosteroids, catecholamines and advancing nutrition push requirements up; resolving sepsis, a steroid taper, and interrupted feeds or a lapsed TPN bag pull them down — the classic setup for overnight hypoglycemia.
- Stopping: the label gives a mean half-life of about 20 minutes after a 0.1 unit/kg IV dose and about an hour after 0.2 unit/kg, so circulating insulin is gone within roughly an hour of stopping the pump. In DKA, overlap the first basal subcutaneous dose 1–2 hours before discontinuation.
Limitations
- Adults only, and IV regular insulin only — not subcutaneous regimens, U-500, or the rapid-acting-analog pathway some units use for mild-to-moderate DKA.
- The hyperkalemia order — insulin with dextrose — is a single push, not an infusion, and is not computed here.
- No titration advice: the tool shows what the ordered rate delivers, never when to change it.
- The 24-h column is a projection of one rate held for a day, not the insulin actually delivered — do not use it to size the subcutaneous transition dose. It counts the infusion only; boluses are additive.
- Weight is entered as your local protocol defines it. The consensus states the fixed rate per kg without specifying a weight basis; most protocols use actual body weight.
Frequently Asked Questions (FAQ)
1. Why does units/hr equal mL/hr on a standard insulin infusion?
The ASHP adult standard concentration for a regular insulin infusion is 1 unit/mL, usually 100 units in 100 mL of saline. At that concentration the pump rate in mL/hr is identical to the dose in units/hr — a 4 units/hr order runs at 4.00 mL/hr. The equality breaks at any other concentration; the custom mode covers those.
2. What insulin infusion rate is used for DKA?
The 2024 ADA/EASD consensus recommends fixed-rate IV regular insulin at 0.1 units/kg/hr; an initial 0.1 units/kg bolus is optional, mainly when venous access is expected to be delayed. Below 250 mg/dL, dextrose is added and the rate reduced to 0.05 units/kg/hr until the ketoacidosis resolves. The familiar 50–75 mg/dL per hour fall is a 2009 figure the 2024 report does not restate.
3. Why must potassium be checked before starting an insulin infusion?
Insulin drives potassium into cells, so a patient already below 3.5 mmol/L can develop dangerous hypokalemia and arrhythmias within hours. Below 3.5 mmol/L the infusion is held while potassium is replaced; at 3.5–5.0 mmol/L potassium is added to each liter of fluid as insulin runs. Total-body potassium is depleted in DKA even when the first value looks normal or high.
4. What glucose target does an ICU insulin infusion aim for?
For most critically ill adults the target is 140–180 mg/dL, started once glucose is persistently 180 mg/dL or higher. NICE-SUGAR found that a tighter 81–108 mg/dL target increased 90-day mortality versus a conventional target of 180 mg/dL or less, with severe hypoglycemia far more common in the tight arm. DKA is the exception: the rate there is driven by ketone clearance, not by this target.
5. How is an IV insulin infusion stopped safely?
The label gives a mean half-life of about 20 minutes after a 0.1 unit/kg IV dose, so an abrupt stop leaves almost no circulating insulin — in DKA that causes rebound ketoacidosis. Give the first long-acting basal subcutaneous dose 1–2 hours before the pump stops, once the crisis has resolved and the patient can eat. The full transition is in our DKA and HHS guideline.
Related Calculators
📖 Sources:
- Umpierrez, G. E., Davis, G. M., ElSayed, N. A., et al. (2024). Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care, 47(8), 1257-1275. PMID: 39052901.
- American Diabetes Association Professional Practice Committee. (2026). 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026. Diabetes Care, 49(Suppl 1), S339-S355. PMID: 41358892.
- NICE-SUGAR Study Investigators. (2009). Intensive versus Conventional Glucose Control in Critically Ill Patients. New England Journal of Medicine, 360(13), 1283-1297. PMID: 19318384.
- Jacobi, J., Bircher, N., Krinsley, J., et al. (2012). Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Critical Care Medicine, 40(12), 3251-3276. PMID: 23164767.
- American Society of Health-System Pharmacists. Standardize 4 Safety — Adult Continuous Infusion Standards, updated June 2026. ASHP, Bethesda, MD.
- Humulin R (insulin human) injection, for subcutaneous or intravenous use [Prescribing Information]. Eli Lilly and Company, Indianapolis, IN. DailyMed.
- Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009). Hyperglycemic Crises in Adult Patients With Diabetes. Diabetes Care, 32(7), 1335-1343. PMID: 19564476.
- Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020). Diabetic ketoacidosis. Nature Reviews Disease Primers, 6(1), 40. PMID: 32409703.
📝 How to cite this page:
DosePilot Medical Team. Insulin Infusion Rate Calculator. DosePilot. Published August 14, 2026. Last medically reviewed August 2026. https://dosepilot.com/calc/insulin-infusion-rate-calculator/
⚠️ Disclaimer:
This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. Insulin is a high-alert medication, and concentrations and titration protocols vary between institutions — always follow the approved product information and local policy. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context.